Navigation Links
Rib-X Pharmaceuticals to Present at the 49th ICAAC
Date:9/10/2009

NEW HAVEN, Conn., Sept. 10 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery, development and commercialization of novel antibiotics for the treatment of acute care antibiotic-resistant infections, today announced that seven posters have been accepted for presentation at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) taking place in San Francisco, CA on September 12-15, 2009. Details on these presentations are as follows:


                                                                 Location/
                                                                 Poster/
    Date      Time      Session         Title                    Presentation

    Sept. 13  11:15am-  Oxazolidinones  In Vitro Activity of     Hall B
              1:15pm                    Radezolid against MRSA   Poster #277
                                        Causing Skin and Wound   Present-
                                        Infections from the      ation
                                        United States, Europe,   #E-810
                                        and Asia

    Sept. 13  11:15am-  New Research    Novel Antibiotic Classes Hall B
              1:15pm    Technologies    to Treat Gram-Negative   Poster #332
                        and             Infections               Present-
                        Methodologies                            ation
                                                                 #F2-861

    Sept. 14  11:15am-  Antibiotic      Anti-MRSA Properties of  Hall B
              1:15pm    Resistance in   Delafloxacin: Mutant     Poster #101
                        Staphylococcus  Analysis and             Present-
                        aureus          Characterization         ation
                                                                 #C1-136
'/>"/>
SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Rib-X Pharmaceuticals Antibiotic Drug Discovery Platform Discovers Novel Compounds with Activity Against Key Multiple Drug Resistant Gram-negative Bacteria
2. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia
3. Rib-X Pharmaceuticals, Inc. Appoints Dr. Russell Greig to Board of Directors
4. Rib-X Pharmaceuticals Announces Presentations at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
5. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing
6. Rib-X Pharmaceuticals to Present at the 2008 ICAAC/IDSA Joint Meeting
7. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
8. Rib-X Pharmaceuticals to Present at Cambridge Healthtech Institutes 2nd Annual Challenge of Antibacterial Development Conference
9. Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
10. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of September 2009
11. Dont Wait to Innovate: Future Pharmaceuticals Magazine Releases Its Issue on Innovation in IT, Cell-Based Therapy and Supply Chains
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... The identification of protein-coding variants ... accelerated by exome sequencing. Built on Roche NimbleGen’s ... SeqCap EZ Developer system has been a proven ... additionally present how he achieved coverage statistics similar ... mouse exome kits. With over 236,000 SNPs and ...
(Date:8/22/2014)... 22, 2014 “Our nation's healthcare ... a national disgrace. Furthermore, every governmental and professional ... current, deplorable state of unorganized dysfunction shares in ... to merely serve as a device to use ... colossal failure(s) that have accumulated through the years ...
(Date:8/21/2014)... 21, 2014  BioSpecifics Technologies Corp. (NASDAQ: ... in class collagenase-based products marketed as XIAFLEX ® ... U.S. and XIAPEX ® in the EU, ... randomized, double-blind Phase 2a study of CCH for ... panniculopathy. The results showed that all three doses ...
(Date:8/21/2014)... 21, 2014 DNA vaccine pioneer ... its development of JRC-LAMP-vax, an innovative and safe potential ... IC studies began this month in Hawaii, moving the ... , The Japanese red cedar releases pollen that causes ... Mountain Cedar pollen wreaks similar havoc in Colorado, New ...
Breaking Biology Technology:Efficient Identification of Protein-Coding Variants in a Model Organism Through Exome Sequencing, New Webinar Hosted by Xtalks 25 Great Mistakes in Healthcare and How to Fix Them by Dr. Ira Williams 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 2BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 3BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 4BioSpecifics Technologies Corp. Announces Positive Data from Phase 2a Study of CCH for Treatment of Cellulite 5Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 2Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 3Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 4
... , ... want to increase sales success need to understand Key Performance Indicators (KPIs) that gauge ... to utilize KPIs to generate more business and income in a new article at ... ...
... Creating catalysts that can operate efficiently and last a ... from the lab bench to the assembly line. The precious ... platinum has two major downsides: It is expensive, and it ... new study, chemists at Brown University report a promising advance. ...
... May 24 Newport Corporation (Nasdaq: NEWP ) today announced ... May 25, 2010 , at 3:30 pm Pacific time (6:30 ... C Room of Loews Santa Monica Beach Hotel in Santa Monica, Calif. ... The 25-minute presentation by Senior ...
Cached Biology Technology:Use Key Performance Indicators to Generate Sales Success Says Expert Lenann McGookey Gardner 2Brown chemists report promising advance in fuel-cell technology 2Newport Corporation to Present at B. Riley & Co. Investor Conference Tomorrow, May 25 2
(Date:8/22/2014)... finally be able to purchase fuel cell cars from ... most of the cars will run on hydrogen made ... global warming. , Now scientists at Stanford University have ... AAA battery to produce hydrogen by water electrolysis. ... that split liquid water into hydrogen and oxygen gas. ...
(Date:8/22/2014)... birds and the bees. But that old expression ... The fertilization process for flowering plants is particularly ... and female reproductive cells. New research from an ... and including Carnegie,s Wolf Frommer, David Ehrhardt, and ... process that guides flowering plant fertilization. It is ...
(Date:8/21/2014)... Ga. An international team of scientists including researchers from ... Brassica napus commonly known as canolain the journal Science ... the plant, which is used widely in farming and industry. ... its native Europe, but the winter crop is increasingly cultivated ... its naturally low levels of saturated fat and rich supply ...
Breaking Biology News(10 mins):Stanford scientists develop a water splitter that runs on an ordinary AAA battery 2Stanford scientists develop a water splitter that runs on an ordinary AAA battery 3Calcium and reproduction go together 2Canola genome sequence reveals evolutionary 'love triangle' 2
... pledged to participate in ELIXIR ( www.elixir-europe.org ), a ... research in Europe. With one of Europe,s larger economies ... infrastructure is well placed to continue its excellent progress. ... sustainable infrastructure for managing biological data to support research ...
... the "fuel" that drives electric cars in effect, the vehicles, ... must be avoided. A battery,s "comfort zone" lies between 20C and ... summer can push a battery,s temperature well beyond that range. The ... of 45C instead of 35C halves its service life. And batteries ...
... of Medicine have identified five rare mutations in a single gene ... an autism spectrum disorder (ASD). Mutations in the AFF2 gene, ... why autism spectrum disorders affect four times as many boys as ... out of 202) of boys examined. Mutations in X chromosome genes ...
Cached Biology News:Italy pledges to be part of ELIXIR research infrastructure 2Keeping electric vehicle batteries cool 2Mutations in autism susceptibility gene increase risk in boys 2
... Channel Cell Lines ,High Quality, Functionally-Validated, Ion ... well known for having a critical role ... have a key function in pain, CNS ... channels have been investigated in therapeutic areas, ...
Mouse polyclonal antibody raised against a partial recombinant CD320. NCBI Entrez Gene ID = 51293...
Mouse monoclonal antibody raised against a partial recombinant CHD8. NCBI Entrez Gene ID = CHD8...
Mouse monoclonal antibody raised against a partial recombinant DENR. NCBI Entrez Gene ID = DENR...
Biology Products: